This technology has already elucidated several well‐defined mechanistic pathways—such as the DMN cholinergic–splenic nerve–anti‐inflammatory axis, and the CeM–CRH–sympathetic nerve–tumor progression circuit. This evidence concerns the gene CRH and neoplasm.